Fingerprint
Dive into the research topics of 'Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically